Compare AORT & WD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AORT | WD |
|---|---|---|
| Founded | 1984 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.1B |
| IPO Year | 1996 | 2010 |
| Metric | AORT | WD |
|---|---|---|
| Price | $38.40 | $45.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $48.76 | ★ $83.33 |
| AVG Volume (30 Days) | ★ 461.3K | 250.5K |
| Earning Date | 05-15-2026 | 05-29-2026 |
| Dividend Yield | N/A | ★ 5.65% |
| EPS Growth | ★ 165.62 | N/A |
| EPS | 0.21 | ★ 1.64 |
| Revenue | $298,836,000.00 | ★ $1,234,306,000.00 |
| Revenue This Year | $13.95 | $21.20 |
| Revenue Next Year | $11.16 | $10.20 |
| P/E Ratio | $181.05 | ★ $23.17 |
| Revenue Growth | ★ 18.01 | 8.99 |
| 52 Week Low | $21.97 | $46.53 |
| 52 Week High | $48.25 | $90.00 |
| Indicator | AORT | WD |
|---|---|---|
| Relative Strength Index (RSI) | 45.22 | 22.33 |
| Support Level | $30.24 | N/A |
| Resistance Level | $44.29 | $66.25 |
| Average True Range (ATR) | 1.70 | 2.93 |
| MACD | 0.09 | -1.73 |
| Stochastic Oscillator | 63.64 | 15.18 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Walker & Dunlop Inc is a United States-based commercial real estate finance company. It is principally engaged in originating, selling, and servicing a number of multifamily and other commercial real estate financing products that are sold under the programs of Freddie Mac, Fannie Mae, Ginnie Mae, and the Federal Housing Administration. The company is managed based on three reportable segments: Capital Markets (CM), Servicing & Asset Management (SAM), and Corporate. The company generates a majority of total revenue from gains from mortgage banking activities and servicing fees. It conducts business solely in the United States.